Coloplast A/S COLOPLAST B ORD SHS/  DK0060448595  /

London International
10/28/2020  7:02:17 PM Chg. -5.98 Volume Bid10/28/2020 Ask10/28/2020 Market Capitalization Dividend Y. P/E Ratio
954.82DKK -0.62% 126,954
Turnover: 120.9 mill.
924.00Bid Size: 1,000 962.00Ask Size: 1,000 182.37 bill.DKK 1.81% 51.40

Business description

Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Coloplast's business includes ostomy care, urology and continence care, and wound and skin care.

Management board & Supervisory board

Kristian Villumsen
Management board
Anders Lonning-Skovgaard, Allan Rasmussen, Paul Marcun
Supervisory board
Lars Rasmussen, Birgitte Nielsen, Carsten Hellmann, Jette Nygaard-Andersen, Jørgen Tang-Jensen, Niels Peter Louis-Hansen, Nikolaj Kyhe Gundersen, Roland Vendelbo Pedersen, Thomas Barfod

Company data

Name: Coloplast Group
Address: Holtedam 1-3,DK-3050 Humlebaek
Phone: +45-4911-1111
Fax: -
Industry: Commodities
Sector: Chemicals
Sub sector: -
End of financial year: 9/30
Free Float: 64.20%
IPO date: -

Investor relations

Name: Ellen Bjurgert
IR phone: +45-4911-3376
IR Fax: +45-4911-1555
IR e-mail:

Company calendar

CW 45 | 11/3/2020 4th Quarter/Annual Report
CW 49 | 12/3/2020 General Shareholder Meeting
CW 50 | 12/8/2020 Dividend Payment

Main Shareholders

Niels Peter Louis-Hansen
Aage og Johanne Louis-Hanses Fond
Benedicte Find